Hormonal control of plasminogen activator secretion in ZR-75-1 human breast cancer cells in culture

Karen K. Huff, Marc E. Lippman

Research output: Contribution to journalArticle

40 Scopus citations

Abstract

Activity of secreted plasminogen activator (PA) by ZR-75-1 human breast cancer cells in culture is shown to be altered by the addition of physiologically relevant concentrations of the hormones 17β-estradiol (E2), insulin, and dexamethasone. After 48 h, E2 stimulated PA activity 6-fold at concentrations as low as 10-12 M. This stimulation was prevented by the addition of actinomycin D and cycloheximide. The antiestrogen tamoxifen reduced estrogen stimulation of PA, but had slight stimulatory effects on PA secretion by itself. Insulin (5 x 10-10 M) induced a 2-fold increase in PA activity. Effects of insulin and E2 were additive, suggesting independent sites of control of PA production. Dexamethasone (10-8 M) decreased PA activity by 20%, but did not inhibit cell growth at the concentration tested. These data suggest that secreted PA activity is differentially regulated by hormones and that effects of PA and growth do not occur in parallel.

Original languageEnglish (US)
Pages (from-to)1702-1710
Number of pages9
JournalEndocrinology
Volume114
Issue number5
DOIs
StatePublished - Jan 1 1984

ASJC Scopus subject areas

  • Endocrinology

Fingerprint Dive into the research topics of 'Hormonal control of plasminogen activator secretion in ZR-75-1 human breast cancer cells in culture'. Together they form a unique fingerprint.

  • Cite this